Aptevo Therapeutics News, Aptevo Therapeutics Quote, APVO Quote

Aptevo Therapeutics (NQ:APVO) Delayed: 1.85 +0.01 (0.54%)

Prev. Close

$1.84

Today 6M 1Y 5Y

Open

$1.82

52 Wk High

$4.33

52 Wk Low

$1.80

Day High

$1.88

Day Low

$1.76

P/E

N/A

EPS

$0.00

Volume

44,147

Friends, Peers and Foes (?): FMST (more...)

ALERTS | RSS

Sep 3, 2026 08:06 AM Aptevo reports 93% clinical benefit rate in TP53-mutated AML trial
Sep 3, 2026 08:06 AM Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
Aug 26, 2026 04:05 PM Form D Aptevo Therapeutics Inc.
Aug 21, 2026 04:16 PM Form PRE 14A Aptevo Therapeutics Inc. For: Aug 21
Aug 21, 2026 04:13 PM Aptevo Therapeutics files prospectus for resale of 6.4M shares
Aug 21, 2026 04:11 PM Form S-1 Aptevo Therapeutics Inc.
Aug 21, 2026 04:06 PM Form 8-K Aptevo Therapeutics Inc. For: Aug 21
Aug 14, 2026 02:42 PM Form SCHEDULE 13G/A Aptevo Therapeutics Inc. Filed by: CVI Investments, Inc.
Aug 14, 2026 08:16 AM Form 10-Q Aptevo Therapeutics Inc. For: Jun 30
Aug 14, 2026 08:10 AM Form 8-K Aptevo Therapeutics Inc. For: Aug 14

Entities mentioned with APVO

View All Entities